From: SSEP N20 and P25 amplitudes predict poor and good neurologic outcomes after cardiac arrest
n = 82 | CPC3–4–5 n = 64 | CPC1–2 n = 18 | p |
---|---|---|---|
CA-SSEP delay, days, median (IQR) | 3 (2.5–4) | 3 (2–4) | 0.62 |
SSEP responses: | 0.01 | ||
Bilaterally absent «AA» | 19 (30%) | 0 | |
Unilaterally present «AP» | 4 (6%) | 0 | |
Bilaterally present «PP» | 41 (64%) | 18 (100%) | |
N20-Baseline amplitude (µV) of the «PP» patterns, median | 0.93 (0–2.05) | 1.56 (1.24–2.75) | 0.008 |
N20–P25 amplitude (µV) of the «PP» patterns, median MD n = 3 | 0.57 (0–1.43) | 2.64 (1.39–3.80) | < 0.0001 |
NSE peak at day 2, median (µg/l) | 96.5 (46–240) | 29.5 (20–42) | < 0.0001 |
NSE peak at day 3, median (µg/l) | 157 (54–353) | 21 (16–36) | < 0.0001 |
Highly malignant EEG, n (%) | 23 (34.4%) | 0 (0%) | 0.0021 |
Malignant EEG, n (%) | 32 (50%) | 2 (11%) | 0.0029 |
Benign EEG, n (%) | 9 (14%) | 16 (89%) | < 0.0001 |
Status myoclonus n (%) | 36 (56.3%) | 1 (5.6%) | < 0.0001 |